[NKTR] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -23.61%
YoY- -16.99%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 21,594 24,822 23,647 50,573 28,222 38,018 24,728 -2.23%
PBT -137,081 -90,267 -122,875 -138,451 -119,495 -95,527 -63,733 13.60%
Tax -63 126 92 200 -983 265 133 -
NP -137,018 -90,393 -122,967 -138,651 -118,512 -95,792 -63,866 13.56%
Tax Rate - - - - - - - -
Total Cost 158,612 115,215 146,614 189,224 146,734 133,810 88,594 10.18%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -634.52 -364.16 -520.01 -274.16 -419.93 -251.96 -258.27 16.15%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.73 -0.49 -0.68 -0.78 -0.68 -0.60 -0.42 9.64%
EPS Diluted -0.73 -0.49 -0.68 -0.78 -0.68 -0.60 -0.42 9.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.